Vitiligo-like lesions developing upon immune checkpoint inhibition in advanced melanoma

Eur J Dermatol. 2020 Feb 1;30(1):72-73. doi: 10.1684/ejd.2020.3732.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents, Immunological / adverse effects*
  • Humans
  • Immune Checkpoint Inhibitors / adverse effects*
  • Melanoma / drug therapy*
  • Melanoma / pathology
  • Nivolumab / adverse effects*
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology
  • Vitiligo / chemically induced*

Substances

  • Antineoplastic Agents, Immunological
  • Immune Checkpoint Inhibitors
  • Nivolumab